resiquimod has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caskey, L; Earp, HS; Holtzhausen, A; Hunter, D; Story, C; Ubil, E | 1 |
| Duong, HTT; Jeong, JH; Kim, ES; Kim, HK; Kim, J; Kim, JE; Kim, NW; Kim, S; Kim, SY; Lee, DS; Lee, JE; Lee, JH; Lee, MS; Lim, SY; Lim, YT; Yin, Y | 1 |
| Hobohm, U; Linnebacher, M; Maletzki, C; Savai, R | 1 |
3 other study(ies) available for resiquimod and Experimental Neoplasms
| Article | Year |
|---|---|
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.
Topics: Animals; B7-H1 Antigen; Calcium-Binding Proteins; Carrier Proteins; Cytokines; Humans; Imidazoles; Macrophages; Membrane Glycoproteins; Mice; Mice, Knockout; Neoplasms, Experimental; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2018 |
Enhanced Cancer Vaccination by In Situ Nanomicelle-Generating Dissolving Microneedles.
Topics: Adjuvants, Immunologic; Animals; Antigen-Presenting Cells; Antigens, Neoplasm; Cancer Vaccines; Drug Delivery Systems; Female; HCT116 Cells; Humans; Imidazoles; Lymph Nodes; Mice; Mice, Inbred C57BL; Micelles; Nanoparticles; Needles; Neoplasms, Experimental; Polymers; RAW 264.7 Cells; Surface-Active Agents; Vaccination | 2018 |
Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Flagellin; Humans; Imidazoles; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mistletoe; Models, Molecular; Neoplasms, Experimental; Pancreatic Neoplasms; Phytotherapy; Plant Lectins; Protein Conformation; Shiga Toxin; Time Factors; Toll-Like Receptors; Treatment Outcome; Tumor Burden | 2013 |